Oracle Investment Management

The Oracle Investment Management Inc latest Q4 13F filings reported over $796 Million in value. It is a focus fund with 19 securities concentration of 100% weights. Oracle Investment Management Inc largest holding is Quidel Corporation with over $316 Million in market value. The following shows the fund statistics and portfolio details.

Period: Report DateNumber of StocksPortfolio ValuePortfolio Return
Q4_20202021-02-1619$796,349,0005.93%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightsComputed PriceShares Change %
DermTech Inc. DMTKBUY$14,5980.000%1.83%$32.440.000%
Biodesix Inc.BDSXBUY$4,1940.000%0.53%$17.810.000%
Translate Bio Inc.TBIOBUY$1,8430.000%0.23%$18.430.000%
Quidel Corp.QDELDECR$316,080-0.198%39.69%$179.65-0.020%
Agenus Inc.AGENDECR$37,691-0.283%4.73%$3.18-0.098%
Accelerate Diagnostics Inc.AXDXDECR$28,851-0.339%3.62%$7.58-0.070%
Soleno Therapeutics Inc.SLNODECR$7,084-0.231%0.89%$1.930.000%
Motus GI Holdings Inc.MOTSDECR$3,609-0.030%0.45%$0.950.000%
Biogen Inc.BIIBDECR$903-0.137%0.11%$244.850.000%
ContraFect Corp.CFRXDECR$846-0.044%0.11%$5.050.000%
Biohaven Pharmaceutical Holding Company Ltd.BHVNINCR$184,1280.365%23.12%$85.710.035%
Aspira Women's Health Inc.AWHINCR$58,0221.175%7.29%$6.710.000%
OPKO Health Inc.OPKINCR$52,0270.056%6.53%$3.95-0.014%
Pacific Biosciences of California Inc.PACBINCR$44,6551.628%5.61%$25.940.000%
BioCryst Pharmaceuticals Inc.BCRXINCR$22,2071.560%2.79%$7.450.180%
Antares Pharma Inc.ATRSINCR$7,5810.652%0.95%$3.990.118%
Y-mAbs Therapeutics Inc.YMABINCR$6,2555.462%0.79%$49.514.011%
Amarin Corporation plcAMRNINCR$5,0500.181%0.63%$4.890.017%
Biolase Inc.BIOLINCR$7250.517%0.09%$0.420.000%